GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Cash Flow from Discontinued Operations

Tevogen Bio Holdings (FRA:G28) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Tevogen Bio Holdings's cash flow from discontinued operations for the three months ended in Mar. 2025 was €0.00 Mil. It means Tevogen Bio Holdings received €0.00 Mil from the sale of part of business quarterly. Tevogen Bio Holdings's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2025 was €0.00 Mil.

Tevogen Bio Holdings Cash Flow from Discontinued Operations Historical Data

The historical data trend for Tevogen Bio Holdings's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Cash Flow from Discontinued Operations Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Cash Flow from Discontinued Operations
- - - -

Tevogen Bio Holdings Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Tevogen Bio Holdings Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tevogen Bio Holdings Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
ADCT LXRX RNAC GLUE NGNE THRD AVIR ALLO ANNX FHTX VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
TVGN:USA G28:Germany
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Website
https://www.tevogen.com
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines